Abstract
Some patients with Guillain–Barré syndrome require respiratory management by tracheotomy and/or nutritional management by tube feeding; however, few studies have reported the follow-up course in these patients. The objective of this study was to investigate the follow-up course of tracheotomy and gastrostomy in patients with Guillain–Barré syndrome. The study subjects were 50 patients with Guillain–Barré syndrome (25 males, 25 females; mean age, 51.1 ± 18.7 years) who were admitted to the Hiroshima City Rehabilitation Hospital during the period from April 2008 to December 2015. We retrospectively reviewed the medical records to determine the presence or absence of tracheotomy and/or feeding tube, and the timing of withdrawal from these treatments. During the acute phase, 15 patients underwent tracheotomy and 14 underwent tube feeding management. A tracheotomy tube was inserted for 110 days or longer in five patients, and four of these five patients also had a gastrostomy tube inserted. Among the 14 patients in the tube feeding group, seven underwent nasal feeding and seven underwent percutaneous endoscopic gastrostomy. All patients had the nasal tube removed (mean duration of nasal tube placement, 62.1 ± 46.5 days); however, the gastrostomy tube could not be removed in two patients. Our findings indicate that patients in the acute phase of Guillain–Barré syndrome carry a relevant risk of long-term tube feeding and prolonged need of an artificial airway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Van der Meché FG, Van Doorn PA, Meulstee J, Jennekens FG. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol. 2001;45:133–9.
Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366:1653–66.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123–33.
McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology. 2009;32:150–63.
Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet. 1997;349:225–30.
Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988;51:605–12.
Sunderrajan EV, Davenport J. The Guillain-Barré syndrome: pulmonary-neurologic correlations. Medicine (Baltimore). 1985;64:333–41.
Winer JB. Guillain-Barré syndrome. BMJ. 2008;337:227–31.
Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86:1516–20.
Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration–aspiration scale. Dysphagia. 1996;11:93–8.
Chumney D, Nollinger K, Shesko K, Skop K, Spencer M, Newton RA. Ability of functional independence measure to accurately predict functional outcome of stroke-specific population: systematic review. J Rehabil Res Dev. 2010;47:17–29.
Inokuchi H, Yasunaga H, Nakahara Y, Horiguchi H, Ogata N, Fujitani J, Matsuda S, Fushimi K, Haga N. Effect of rehabilitation on mortality of patients with Guillain-Barre syndrome: a propensity-matched analysis using nationwide database. Eur J Phys Rehabil Med. 2014;50:439–46.
Cheng BC, Chang WN, Chang CS, Tsai NW, Chang CJ, Hung PL, Wang KW, Chen JB, Tsai CY, Hsu KT, Chang HW, Lu CH. Predictive factors and long-term outcome of respiratory failure after Guillain-Barré syndrome. Am J Med Sci. 2004;327:336–40.
Fourrier F, Robriquet L, Hurtevent JF, Spagnolo S. A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barré syndrome. Crit Care. 2011;15:R65.
Walgaard C, Lingsma HF, Ruts L, Drenthen J, van Koningsveld R, Garssen MJ, van Doorn PA, Steyerberg EW, Jacobs BC. Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. 2010;67:781–7.
Nguyen TN, Badjatia N, Malhotra A, Gibbons FK, Qureshi MM, Greenberg SA. Factors predicting extubation success in patients with Guillain-Barré syndrome. Neurocrit Care. 2006;5:230–4.
Ropper AH, Kehne SM. Guillain-Barré syndrome: management of respiratory failure. Neurology. 1985;35:1662–5.
Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology. 2001;56:758–65.
Chiò A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology. 2003;60:1146–50.
Van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol. 2007;6:589–94.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Yoshida, M., Ikeda, J., Urikane, Y. et al. Prevalence of Tracheotomy and Percutaneous Endoscopic Gastrostomy in Patients with Guillain–Barré Syndrome. Dysphagia 32, 236–240 (2017). https://doi.org/10.1007/s00455-016-9750-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00455-016-9750-6